Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer.

Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer / PETRIOLI, ROBERTO; ROVIELLO, GIANDOMENICO; FIASCHI, ANNA IDA; LAERA, LETIZIA; MIANO, SALVATORA TINDARA; MARRELLI, DANIELE; ROVIELLO, FRANCO; Bianco, Vincenzo; Francini, Edoardo. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - STAMPA. - 11:(2015), pp. 2563-2574. [10.2217/fon.15.105]

Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer

ROVIELLO, GIANDOMENICO;LAERA, LETIZIA;Francini, Edoardo
2015

Abstract

Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer.
2015
FUTURE ONCOLOGY
11
2563
2574
Goal 3: Good health and well-being for people
PETRIOLI, ROBERTO; ROVIELLO, GIANDOMENICO; FIASCHI, ANNA IDA; LAERA, LETIZIA; MIANO, SALVATORA TINDARA; MARRELLI, DANIELE; ROVIELLO, FRANCO; Bianco, V...espandi
1a - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer.pdf

Accesso chiuso

Dimensione 1.34 MB
Formato Adobe PDF
  Richiedi una copia
1.34 MB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1156832
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact